Literature DB >> 32031908

Characterization of the First mecA-Positive Multidrug-Resistant Staphylococcus pseudintermedius Isolated from an Argentinian Patient.

Paula Gagetti1, Laura Errecalde2, Alice R Wattam3, Denise De Belder1, Matthew Ojeda Saavedra4, Alejandra Corso1, Adriana E Rosato4.   

Abstract

Staphylococcus pseudintermedius is commonly associated with colonization or infection in dogs, and was identified as a novel species within the genus Staphylococcus in 2006. Methicillin resistance emerged in S. pseudintermedius during the last decade. We describe here a genomic characterization of the first methicillin-resistant S. pseudintermedius (MRSP) recovered from a human patient in Argentina. The strain was phenotypically identified as MRSP 8510 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and antimicrobial susceptibility testing. We assessed genetic characterization by mecA PCR, SCCmec (staphylococcal chromosomal cassette) typing, and whole-genome sequencing. MRSP 8510 was phenotypically resistant to six classes of antimicrobial agents, consistent with the genes found in its genome. We concluded that MRSP 8510 was a multidrug-resistant ST1412 isolate. This study highlights the importance of the detection and characterization of pathogens with potential risks of zoonotic transmission to humans, as they may constitute a reservoir of genes associated with antimicrobial resistance.

Entities:  

Keywords:  MDR; MRSP; Staphylococcus pseudintermedius

Mesh:

Substances:

Year:  2020        PMID: 32031908      PMCID: PMC7368382          DOI: 10.1089/mdr.2019.0308

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  29 in total

1.  Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus.

Authors:  Catarina Milheiriço; Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

2.  Epidemiology, Clinical Characteristics, and Antimicrobial Susceptibility Profiles of Human Clinical Isolates of Staphylococcus intermedius Group.

Authors:  Melanie L Yarbrough; William Lainhart; C A Burnham
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

3.  Human infections due to Staphylococcus pseudintermedius, an emerging zoonosis of canine origin: report of 24 cases.

Authors:  R Somayaji; M A R Priyantha; J E Rubin; D Church
Journal:  Diagn Microbiol Infect Dis       Date:  2016-05-12       Impact factor: 2.803

4.  Comparative genomic analysis at the PATRIC, a bioinformatic resource center.

Authors:  Alice R Wattam; Joseph L Gabbard; Maulik Shukla; Bruno W Sobral
Journal:  Methods Mol Biol       Date:  2014

5.  First case of Staphylococcus pseudintermedius infection in a human.

Authors:  Lieve Van Hoovels; Anne Vankeerberghen; An Boel; Kristien Van Vaerenbergh; Hans De Beenhouwer
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

6.  Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR.

Authors:  P Vannuffel; J Gigi; H Ezzedine; B Vandercam; M Delmee; G Wauters; J L Gala
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  Changes in the population structure of canine methicillin-resistant Staphylococcus pseudintermedius in Poland.

Authors:  Magdalena Kizerwetter-Świda; Dorota Chrobak-Chmiel; Magdalena Rzewuska; Marian Binek
Journal:  Vet Microbiol       Date:  2017-07-25       Impact factor: 3.293

Review 8.  Systematic Review on Global Epidemiology of Methicillin-Resistant Staphylococcus pseudintermedius: Inference of Population Structure from Multilocus Sequence Typing Data.

Authors:  Teresa Pires Dos Santos; Peter Damborg; Arshnee Moodley; Luca Guardabassi
Journal:  Front Microbiol       Date:  2016-10-18       Impact factor: 5.640

9.  Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center.

Authors:  Alice R Wattam; James J Davis; Rida Assaf; Sébastien Boisvert; Thomas Brettin; Christopher Bun; Neal Conrad; Emily M Dietrich; Terry Disz; Joseph L Gabbard; Svetlana Gerdes; Christopher S Henry; Ronald W Kenyon; Dustin Machi; Chunhong Mao; Eric K Nordberg; Gary J Olsen; Daniel E Murphy-Olson; Robert Olson; Ross Overbeek; Bruce Parrello; Gordon D Pusch; Maulik Shukla; Veronika Vonstein; Andrew Warren; Fangfang Xia; Hyunseung Yoo; Rick L Stevens
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

10.  Are Staphylococcus intermedius Infections in Humans Cases of Mistaken Identity? A Case Series and Literature Review.

Authors:  Roberto Viau; Andrea M Hujer; Kristine M Hujer; Robert A Bonomo; Robin L P Jump
Journal:  Open Forum Infect Dis       Date:  2015-07-17       Impact factor: 3.835

View more
  3 in total

1.  Occurrence and characterization of methicillin-resistant Staphylococcus spp. in diseased dogs in Brazil.

Authors:  Flávia Mello Viegas; Jordana Almeida Santana; Brendhal Almeida Silva; Rafael Gariglio Clark Xavier; Cláudia Teixeira Bonisson; Júlia Lara Sette Câmara; Mário Cesar Rennó; João Luis Reis Cunha; Henrique César Pereira Figueiredo; Francisco Carlos Faria Lobato; Rodrigo Otávio Silveira Silva
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

2.  Patterns of antimicrobial, multidrug and methicillin resistance among Staphylococcus spp. isolated from canine specimens submitted to a diagnostic laboratory in Tennessee, USA: a descriptive study.

Authors:  Jennifer Lord; Nick Millis; Rebekah Duckett Jones; Brian Johnson; Stephen A Kania; Agricola Odoi
Journal:  BMC Vet Res       Date:  2022-03-08       Impact factor: 2.741

3.  Volatiles and Antifungal-Antibacterial-Antiviral Activity of South African Salvia spp. Essential Oils Cultivated in Uniform Conditions.

Authors:  Basma Najar; Giulia Mecacci; Valeria Nardi; Claudio Cervelli; Simona Nardoni; Francesca Mancianti; Valentina Virginia Ebani; Simone Giannecchini; Luisa Pistelli
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.